5.04535

QNZ46

• Synonym(e): QNZ46, NMDA Antagonist VIII, 4-[6-Methoxy-2-[(1E)-2-(3-nitrophenyl)ethenyl]-4-oxo-3(4H)-quinazolinyl]-Benzoic acid
• Empirische Formel (Hill-System): C₂₄H₁₇N₃O₆
• CAS-Nummer: 1237744-13-6
• Molekulargewicht: 443.41
• MDL-Nummer: MFCD22666391
• UNSPSC-Code: 12352200

Eigenschaften

• Assay: ≥98% (HPLC)
• Qualitätsniveau: 100
• Form: powder
• Hersteller/Markenname: Calbiochem^®
• Lagerbedingungen: OK to freeze; protect from light
• Farbe: yellow
• Löslichkeit: DMSO: 5 mg/mL
• Lagertemp.: 2-8°C
• InChI: 1S/C24H17N3O6/c1-33-19-10-11-21-20(14-19)23(28)26(17-8-6-16(7-9-17)24(29)30)22(25-21)12-5-15-3-2-4-18(13-15)27(31)32/h2-14H,1H3,(H,29,30)/b12-5+
• InChIKey: GNLVJIICVWDSNI-LFYBBSHMSA-N

Beschreibung

Allgemeine Beschreibung

A noncompetitive and voltage-independent antagonist selective for NR2C/D containing NMDA receptors (IC₅₀ = 6, 3, 229, and >300 µM for NR2C, NR2D, NR2A, and NR2B, respectively). Inhibition on NR2C/D containing NMDA receptors is glutamate-binding, but not glycine-binding, dependent. Represents a new class of noncompetitive subunit-selective NMDA receptor antagonists. With more than 100-fold selectivity for recombinant NMDA receptors over AMPA and kainate receptors.

Biochem./physiol. Wirkung

Primary Target
NMDA receptors

Target IC₅₀: 6, 3, 229, and >300 →M for NR2C, NR2D, NR2A, and NR2B, respectively.

Warnhinweis

Toxicity: Standard Handling (A)

Angaben zur Herstellung

Slight warming is required for complete solubilization.

Rekonstituierung

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.

Sonstige Hinweise

Mayer, M., et al. 2013. Annu. Rev. Physiol.75, 1.

Hansen, K., 2011. J. Neurosci.9, 3650.

Mosley, C., et al. 2010. J. Med. Chem.53, 5476.

Rechtliche Hinweise

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable